Endothelin-1 and vascular tone in subjects with atherogenic risk factors

50Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.

Abstract

Endothelin-1 (ET-1) is a potent vasoconstrictor that increases vascular tone in the resistance vessels of subjects with hypertension. It is unclear whether endogenous ET-1 affects resistance-vessel function equally in patients with other cardiovascular risk factors. Vasoconstriction to ET-1 is mediated principally via the endothelin-A (ETA) receptor on vascular smooth muscle cells. Accordingly, we used an ETA-specific antagonist, BQ-123, to test the hypothesis that endogenous ET-1 increases vascular resistance selectively in subjects with hypertension compared with other risk factors. BQ-123 was infused at 100 nmol/min for 80 minutes into the brachial artery of 10 subjects with hypertension (mean±SEM arterial pressure, 106±5 mm Hg), 12 subjects with hypercholesterolemia (mean±SEM total cholesterol, 7.1±0.2 mmol/L), 10 active smokers (mean±SEM, 42±11 pack-years), and 11 healthy, age-matched individuals. Forearm blood flow (FBF) was measured by venous occlusion plethysmography. BQ-123 dilated resistance arterioles in hypertensive subjects, with FBF's increasing by 46±7% from baseline (P<0,001). BQ-123 increased FBF to a lesser extent in hypercholesterolemic (24±5%, P<0.001) and healthy (20±8%, P=0.007) individuals but did not affect FBF significantly in smokers (10±8%, P=0.185). The vasodilator response in hypertensive subjects, but not in hypercholesterolemic patients or smokers, was significantly greater than that in healthy individuals (P=0.012). Endogenous ET-1, acting via the ETA receptor, increases resistance-vessel tone in subjects with hypertension more than in subjects with hypercholesterolemia or in smokers. These results indicate that ET-1 contributes more to the pathophysiology of hypertension than of other risk factors in subjects without overt atherosclerosis.

References Powered by Scopus

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

10663Citations
N/AReaders
Get full text

Cloning and expression of a cDNA encoding an endothelin receptor

2627Citations
N/AReaders
Get full text

Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor

2481Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Endothelial dysfunction and vascular disease – a 30th anniversary update

679Citations
N/AReaders
Get full text

Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: A statement by the working group on endothelin and endothelial factors of the European society of hypertension

598Citations
N/AReaders
Get full text

Wound healing and infection in surgery: The pathophysiological impact of smoking, smoking cessation, and nicotine replacement therapy: A systematic review

489Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Nohria, A., Garrett, L., Johnson, W., Kinlay, S., Ganz, P., & Creager, M. A. (2003). Endothelin-1 and vascular tone in subjects with atherogenic risk factors. Hypertension, 42(1), 43–48. https://doi.org/10.1161/01.HYP.0000074426.71392.D8

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 10

50%

Researcher 4

20%

Professor / Associate Prof. 3

15%

Lecturer / Post doc 3

15%

Readers' Discipline

Tooltip

Medicine and Dentistry 13

65%

Biochemistry, Genetics and Molecular Bi... 4

20%

Agricultural and Biological Sciences 2

10%

Pharmacology, Toxicology and Pharmaceut... 1

5%

Save time finding and organizing research with Mendeley

Sign up for free